Immortalized Human Hepatocytes - HPV E6/E7, hTERT & MycT58A | T0063

Immortalized Human Hepatocytes - HPV E6/E7, hTERT & MycT58A | T0063

Human hepatocytes are routinely used by the pharmaceutical industry for study of hepatotoxicity, drug clearance, and drug-drug interactions. However, their use is largely impeded by inadequate supply, high cost, high variability, and limited in vitro proliferation capacity. Alternative cell sources include hepatic cell lines and stem-cell derived hepatocytes but most of them do not exhibit sufficient in vivo-like functionality to be of pharmaco-toxicological relevance. In this scenario, immortalized human hepatocytes serve as the optimal in vitro model of the human liver as they are more easily maintained, propagated in culture, and have less intrinsic variation. They provide a valuable tool for investigating metabolic pathways and hepatocyte proliferation-related events.

Immortalization Method:

Serial passaging and transduction with recombinant lentiviruses carrying HPV E6/E7, hTERT & MycT58A genes

BioSafety Level:

II

Organism:

Homo sapiens

Species:

Human

Source Organ:

Liver

Organ Type:

Liver

Growth Properties:

Adherent

Morphology:

Epithelial

Passage Number:

N/A

Population Doubling:

30 - 35 hours

Seeding Density:

5 - 15,000 cells/cm10²; Recommended split ratio of 1:2 to 1:5*
* Do not exceed a split ratio of 1:5

Markers:

N/A

Donor Age:

N/A

Donor Gender:

N/A

Donor Ethnicity:

N/A

Propagation:

Grow cells in culture vessels coated with Collagen I, rat tail. Coat plates at 37.0°C overnight and wash with sterile PBS prior to use.
The base media for this cell line is Prigrow IX medium available at abm Cat. No. to a final concentration of 10%, and Penicillin/Streptomycin Solution to a final concentration of 1%.
Carbon dioxide (CO₂): 5%, Temperature: 37.0°C.
abm does not recommend to use heat-inactivated FBS for cell culture unless specified otherwise.

Quality Control:

N/A

Shipping Condition:

Dry Ice

Storage Condition:

liquid nitrogen or -180C